Arthur R. T. Scheffer

Arthur R. T. Scheffer

Auto-generated profile, based on publicly available information

Arthur R. T. Scheffer

Department of Otorhinolaryngology & Head & Neck Surgery, Radboud University Medical Center, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2010 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
ASArthur R. T. Scheffer
Arthur R. T. Scheffer
CECorrie Erasmus
Corrie Erasmus
KHKaren van Hulst
Karen van Hulst
JLJacques van Limbeek
Jacques van Limbeek
PJPeter H. Jongerius
Peter H. Jongerius
FHFrank J. A. van Den Hoogen
Frank J. A. van Den Hoogen
Drooling is a common problem for children with neurological disorders. Recent estimates suggest a prevalence of nearly 60% in children in special care school, of which 33% could be classified as severe.1 Drooling in these children is usually caused by a combination of low oral sensitivity, infrequent swallowing, poor posture and mental ability, and dysfunctional oral motor control leading to excessive pooling of saliva in the anterior oral cavity and consequently to unintentional saliva loss.2,3 Hypersalivation might only be an issue in children with dyskinesia as a result of hyperkinetic oral movements.4

15 June 2010 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
ASArthur Rt Scheffer
Arthur Rt Scheffer
CECorrie Erasmus
Corrie Erasmus
KHKaren VAN Hulst
Karen VAN Hulst
JLJacques VAN Limbeek
Jacques VAN Limbeek
JRJan J Rotteveel
Jan J Rotteveel
FHFrank Ja VAN Den Hoogen
Frank Ja VAN Den Hoogen
Aim  Botulinum neurotoxin type A (BoNT‐A) has been described as an effective intervention for drooling and is being increasingly adopted. However, its effectiveness compared with established treatments is still unknown. We undertook a within‐participants observational study to examine this.Method  An historic cohort was formed of 19 children and young adults (10 males, nine females) with severe drooling who underwent BoNT‐A injections followed by surgical re‐routing of the submandibular duct at least 6 months later. Mean age at time of admission was 11 years 5 months (range 5–17y) and mean age at the time of surgery was 14 years (range 6–23y). Fifteen children were diagnosed with bilateral cerebral palsy (CP), three with unilateral CP, and one with non‐progressive developmental delay. Gross Motor Function Classification System levels were the following: level I, n=1; level II, n=2; level III, n=7; level IV, n=6; and level V, n=3). The primary outcome was the drooling quotient, which was assessed before each intervention and 8 and 32 weeks thereafter. A multivariate analysis of variance of repeated measures was performed, with the measurement points as the within‐participant variables.Results  The drooling quotient was reduced to a greater extent after surgery than after BoNT‐A administration (p=0.001). Compared with a baseline value of 28, the mean drooling quotient 8 weeks after surgery was 10, and 32 weeks after surgery was 4 (p<0.001). Among the group treated with BoNT‐A, the drooling quotient showed a significant reduction from a baseline value of 30 to 18 after 8 weeks (p=0.02), and a continued but diminished effect after 32 weeks (drooling quotient 22; p=0.05).Interpretation  Both interventions are effective, but surgery provides a larger and longer‐lasting effect.

1 March 2012 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
CECorrie E. Erasmus
Corrie E. Erasmus
KHKaren van Hulst
Karen van Hulst
ASArthur R.T. Scheffer
Arthur R.T. Scheffer
JLJacques van Limbeek
Jacques van Limbeek
FHFrank J.A. van Den Hoogen
Frank J.A. van Den Hoogen
PJPeter H. Jongerius
Peter H. Jongerius

24 October 2013 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
ASA.R.T. Scheffer
A.R.T. Scheffer
KBK.J.A.M. Bosch
K.J.A.M. Bosch
KHK. van Hulst
K. van Hulst
FHF.J.A. van Den Hoogen
F.J.A. van Den Hoogen

6 February 2020 in Journal of Neurology
Verified
Journal Article
Open access
PDF file
SBStijn Bekkers
Stijn Bekkers
KHKaren van Hulst
Karen van Hulst
CECorrie E. Erasmus
Corrie E. Erasmus
CDCorinne Delsing
Corinne Delsing
ASArthur R. T. Scheffer
Arthur R. T. Scheffer
FHFrank J. A. van Den Hoogen
Frank J. A. van Den Hoogen
Background: Drooling is dependent on various clinical variables. However, while drooling proves refractory to two-duct ligation in 40% of patients, predictors for treatment success are sparse and to date there is little evidence why some respond well while others are non-responders. We aim to find predictors for treatment success and study the effectiveness of two-duct ligation for drooling in neurodisabilities. Methods: Fifty-four patients with moderate to severe drooling who had undergone two-duct ligation were screened for inclusion. Four patients were excluded due to missing or unreliable primary outcomes. The average age at the time of surgery was 12 years. Predictors were evaluated for treatment success which was defined as ≥ 50% visual analog scale for severity of drooling and/or drooling quotient reduction from baseline. Treatment effect was measured after 8 and 32 weeks compared to baseline. Results: Age (more mature), adequate posture (no anteflexion), and normal speech are predictors for treatment success. Compared to baseline, drooling quotient was significantly lower at 8 (difference 18.6%, 95% confidence interval 12.3–24.9%) and 32 weeks (difference 10.1%, 95% confidence interval 3.9–16.4%). Compared to baseline, visual analog scale was significantly lower at 8 (difference 45.0, 95% confidence interval 37.0–52.9) and 32 weeks (difference 32.9, 95% confidence interval 25.0–40.7). Conclusions: Age, adequate posture, and a normal speech are predictors for treatment success, are easily determined pre-operatively, and help the clinician providing patient-specific probability of treatment success. There is a significant subjective and objective decrease of drooling after two-duct ligation.

1 August 2011 in Pediatric Neurology
Verified
Journal Article
Closed access
PDF file
CECorrie E. Erasmus
Corrie E. Erasmus
ASArthur R.T. Scheffer
Arthur R.T. Scheffer
KHKaren van Hulst
Karen van Hulst
JLJacques van Limbeek
Jacques van Limbeek
FHFrank J.A. van Den Hoogen
Frank J.A. van Den Hoogen
PJPeter H. Jongerius
Peter H. Jongerius